Showing results (301-310 of 330) with videos related to
Sort By:
Pageof 33
Nuklearmedizin. Nuclear Medicine|February 1, 1995
[Biokinetics of tumor-affinity yttrium preparations--Part 1]K Schomäker, B Hientzsch, W G Franke, et al.Nuklearmedizin. Nuclear Medicine|May 28, 2010
Risk stratification of patients with locally aggressive differentiated thyroid cancer. Results of the MSDS trialBurkhard Riemann, J A Krämer, K W Schmid, et al.European Archives of Psychiatry and Clinical Neuroscience|January 1, 1995
Nocturnal myoclonus syndrome (periodic movements in sleep) related to central dopamine D2-receptor alterationJ Staedt, G Stoppe, A Kögler, et al.Zeitschrift Fur Kardiologie|April 1, 1992
[Assessment with magnetic resonance tomography of anatomy and ventricular function after Mustard correction of transposition of the great arteries]H Kaemmerer, P Theissen, R Kaulitz, et al.Journal of Neural Transmission. General Section|January 1, 1995
Single photon emission tomography (SPET) imaging of dopamine D2 receptors in the course of dopamine replacement therapy in patients with nocturnal myoclonus syndrome (NMS)J Staedt, G Stoppe, A Kögler, et al.Nuklearmedizin. Nuclear Medicine|February 19, 2008
99mTc-MIBI SPECT in primary hyperparathyroidism. Influence of concomitant vitamin D deficiency for visualization of parathyroid adenomasM Schmidt, N Thoma, M Dietlein, et al.European Heart Journal|February 1, 1993
Myocardial indium-111 antimyosin uptake in patients with idiopathic dilated cardiomyopathy: its relation to haemodynamics, histomorphometry, myocardial enteroviral infection, and clinical courseG S Werner, H R Figulla, D L Munz, et al.The American Journal of Cardiology|August 15, 1996
Comparison of dobutamine transesophageal echocardiography and dobutamine magnetic resonance imaging for detection of residual myocardial viabilityF M Baer, E Voth, K LaRosée, et al.Nuklearmedizin. Nuclear Medicine|October 1, 1995
[Biokinetics of tumor-affinity yttrium preparations--2]K Schomäcker, B Hientzsch, W G Franke, et al.Nuklearmedizin. Nuclear Medicine|October 17, 2007
[Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 3)]M Dietlein, J Dressler, W Eschner, et al.Pageof 33